Reply to the comment on "Cost-effectiveness of rivaroxaban for stroke prevention in atrial fibrillation in the Portuguese setting".
Serviço de Cardiologia, Centro Hospitalar de Leiria, Portugal. Electronic address: jaraujomorais@mail.telepac.pt.
João
J
Morais
D000925:Anticoagulants / Q000191:economics*; D001281:Atrial Fibrillation / Q000150:complications*; D006801:Humans; D000069552:Rivaroxaban / Q000191:economics*; D020521:Stroke / Q000517:prevention & control*; D014859:Warfarin / Q000191:economics*
D000925:Anticoagulants; D014859:Warfarin; D000069552:Rivaroxaban